Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Buffett Is Buying J&J. Should You?
Motley Fool
Thursday, August 19, 2010 - 5:32pm
tags:
JNJ, Warren Buffett
Avanir Expected to Shine at the American Neurological Association Meeting
Seeking Alpha
Thursday, August 19, 2010 - 5:30pm
tags:
Avanir, PBA
[video]They Just Don't Get Lilly!
Yahoo/TheStreet.com
Thursday, August 19, 2010 - 11:08am
tags:
Eli Lilly
Traders Gobbling Up Shares of KV Pharmaceutical, Shares Up 9.7% (KV.A)
Comtex Smartrend
Thursday, August 19, 2010 - 10:56am
tags:
KV Pharmaceutical
Novartis sales calls to healthcare providers on the rise
Fierce Pharma
Thursday, August 19, 2010 - 10:36am
tags:
Novartis, drug reps, physicians
Pfizer Menopause Drug Didn't Cause Cancers, Jury Says
Bloomberg
Thursday, August 19, 2010 - 10:34am
tags:
Pfizer, HRT, cancer, Prempro, Wyeth
Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg
Thursday, August 19, 2010 - 10:33am
tags:
Takeda, diabetes, Actos, generics
Will United Therapeutics Burn You?
Motley Fool
Thursday, August 19, 2010 - 10:30am
tags:
United Therapeutics
Human Genome Sciences and GlaxoSmithKline say FDA will make a ruling on Benlysta by December
Yahoo/AP
Thursday, August 19, 2010 - 10:11am
tags:
Human Genome Sciences, GSK, lupus, Benlysta, FDA
GSK Ups Stake in Vaccine JV to Expand China Presence
Seeking Alpha
Thursday, August 19, 2010 - 10:10am
tags:
GSK, vaccines, Shenzhen Neptunus Interlong Bio-technique, China
Endo Pharma climbs on analyst's Opana ER comment
Yahoo/AP
Thursday, August 19, 2010 - 7:38am
tags:
Opana ER, Endo, analyst, painkillers
Why J&J's headache won't go away
CNN/Fortune
Thursday, August 19, 2010 - 7:37am
tags:
JNJ, recalls
J&J Reorganizes Manufacturing After Series of Recalls
Bloomberg Businessweek
Thursday, August 19, 2010 - 7:27am
tags:
recalls, reorganization, JNJ
Any Sanofi Deal For Genzyme May Take Time, At Limited Price
WSJ Online
Wednesday, August 18, 2010 - 4:56pm
tags:
Genzyme, M&A, Sanofi, GSK
Bristol-Myers cancer drug gets faster FDA review
Yahoo/AP
Wednesday, August 18, 2010 - 4:53pm
tags:
Bristol-Myers Squibb, FDA, melanoma, ipilimumab
Lilly CEO Vows Medical Innovations In Full-Page Ad
Pharma Live
Wednesday, August 18, 2010 - 2:37pm
tags:
Eli Lilly, Pharma CEOs, John Lechleiter, R&D, Alzheimer's disease
Dendreon’s Big Pharma Future
Motley Fool
Wednesday, August 18, 2010 - 2:32pm
tags:
Dendreon, Provenge, vaccines, prostate cancer
FDA Panel to Review Cymbalta Thursday
Yahoo/Zacks.com
Wednesday, August 18, 2010 - 2:31pm
tags:
FDA, advisory panels, Cymbalta, Eli Lilly, chronic pain
Biogen Idec licenses Lou Gehrig's disease drug
Yahoo/AP
Wednesday, August 18, 2010 - 10:26am
tags:
Biogen Idec, Lou Gehrig's disease, Knopp, licensing
Judge rules FTC did not improperly pressure Watson
FT.com
Wednesday, August 18, 2010 - 10:16am
tags:
Watson Pharmaceuticals, FTC, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.